VALIANTLAB — Valiant Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMicro CapMomentum Trap

Annual balance sheet for Valiant Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	201	361	1,438	760	331
Net Total Accounts Receivable
Net Total Receivables	1,124	905	498	744	953
Total Inventory
Total Other Current Assets
Total Current Assets	1,497	1,506	2,255	1,926	2,283
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	237	488	927	2,041	2,331
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,744	2,130	3,427	4,009	4,640
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	420	507	291	596	1,194
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,029	1,125	1,058	1,665	1,531
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	715	1,005	2,369	2,343	3,109
Total Liabilities & Shareholders' Equity	1,744	2,130	3,427	4,009	4,640
Total Common Shares Outstanding